A new VC fund backing early-stage medical and healthtech startups is on the hunt for investors
A new venture capital fund looking to back medtech and deep tech health ventures is on the hunt for investors as it looks to raise up to $100 million. Synthesis Capital has emerged out of the MedTech Actuator’s Origin program, which has helped develop more than 70 leading medtech startups the past five years, including… Read more »